Roflumilast is used in people with severe chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) to reduce the number of episodes or worsening of COPD symptoms. Roflumilast is in a class of medications called phosphodiesterase inhibitors. It works by decreasing swelling in the lungs.
Daliresp Available Drugs :
Daliresp ndc# 0456-0095by Forest Laboratories, Inc.
ORAL TABLET with active strength of 500 ug/1started marketing at 28/02/2011 .
Daliresp Search Trends: